AstraZeneca to invest $5 million per year in India till 2005Illustrative image – not actual.

Pharmaceutical major AstraZeneca Plc plans to invest $5 million in India per year from 2001 to 2005.

 

The proposed annual investment would be in addition to the $10 million being invested in the company’s R&D facility in Bangalore, which would henceforth focus only on tuberculosis (TB) research programme. The R&D facility would focus on understanding the mechanism by which the TB microbe evades the immune system and the prevailing treatments by using the latest technology.

 

The company plans to undertake clinical research in a major way in India.

← All latest storiesBack to top →